Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

被引：0

作者：

Begna, Kebede H. ^{[1
]}

Abdallah, Nadine H. ^{[1
]}

Janania-Martinez, Michelle ^{[2
]}

Mangaonkar, Abhishek A. ^{[1
]}

Rangan, Aruna ^{[3
]}

Herrick, Jennifer L. ^{[3
]}

Gangat, Naseema ^{[1
]}

机构：

[1] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA

[2] Sanford Canc Ctr, Div Hematol Oncol, Sioux Falls, SD USA

[3] Mayo Clin, Dept Lab Med & Pathol, Div Hematopathol, Rochester, MN USA

来源：

HAEMATOLOGICA | 2024年 / 109卷 / 02期

关键词：

ADULTS;

D O I：

10.3324/haematol.2023.283740

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：689 / 692

页数：4

共 16 条

[1] Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Radford, John ;

Connors, Joseph M. ;

Dlugosz-Danecka, Monika ;

Kim, Won-Seog ;

Gallamini, Andrea ;

Ramchandren, Radhakrishnan ;

Friedberg, Jonathan W. ;

Advani, Ranjana ;

Hutchings, Martin ;

Evens, Andrew M. ;

Smolewski, Piotr ;

Savage, Kerry J. ;

Bartlett, Nancy L. ;

Eom, Hyeon-Seok ;

Abramson, Jeremy S. ;

Dong, Cassie ;

Campana, Frank ;

Fenton, Keenan ;

Puhlmann, Markus ;

Straus, David J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (04) :310-320

[2] Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia [J].

Bride, Karen L. ;

Vincent, Tiffaney L. ;

Im, Soo-Yeon ;

Aplenc, Richard ;

Barrett, David M. ;

Carroll, William L. ;

Carson, Robin ;

Dai, Yunfeng ;

Devidas, Meenakshi ;

Dunsmore, Kimberly P. ;

Fuller, Tori ;

Glisovic-Aplenc, Tina ;

Horton, Terzah M. ;

Hunger, Stephen P. ;

Loh, Mignon L. ;

Maude, Shannon L. ;

Raetz, Elizabeth A. ;

Winter, Stuart S. ;

Grupp, Stephan A. ;

Hermiston, Michelle L. ;

Wood, Brent L. ;

Teachey, David T. .

BLOOD, 2018, 131 (09) :995-999

[3] Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study [J].

Cerrano, Marco ;

Bonifacio, Massimiliano ;

Olivi, Matteo ;

Curti, Antonio ;

Malagola, Michele ;

Dargenio, Michelina ;

Scattolin, Anna Maria ;

Papayannidis, Cristina ;

Forghieri, Fabio ;

Gurrieri, Carmela ;

Tanasi, Ilaria ;

Zappasodi, Patrizia ;

La Starza, Roberta ;

Fracchiolla, Nicola Stefano ;

Chiusolo, Patrizia ;

Giaccone, Luisa ;

Del Principe, Maria Ilaria ;

Giglio, Fabio ;

Defina, Marzia ;

Favre, Claudio ;

Rizzari, Carmelo ;

Castella, Barbara ;

Pizzolo, Giovanni ;

Ferrara, Felicetto ;

Chiaretti, Sabina ;

Foa, Robin .

HAEMATOLOGICA, 2022, 107 (04) :996-999

[4] Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma [J].

Chen, Robert ;

Gopal, Ajay K. ;

Smith, Scott E. ;

Ansell, Stephen M. ;

Rosenblatt, Joseph D. ;

Savage, Kerry J. ;

Connors, Joseph M. ;

Engert, Andreas ;

Larsen, Emily K. ;

Huebner, Dirk ;

Fong, Abraham ;

Younes, Anas .

BLOOD, 2016, 128 (12) :1562-1566

[5] Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study [J].

Fielding, Adele K. ;

Richards, Susan M. ;

Chopra, Rajesh ;

Lazarus, Hillard M. ;

Litzow, Mark R. ;

Buck, Georgina ;

Durrant, I. Jill ;

Luger, Selina M. ;

Marks, David I. ;

Franklin, Ian M. ;

McMillan, Andrew K. ;

Tallman, Martin S. ;

Rowe, Jacob M. ;

Goldstone, Anthony H. .

BLOOD, 2007, 109 (03) :944-950

[6] Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia [J].

Ganzel, Chezi ;

Kharit, Mira ;

Duksin, Chen ;

Rowe, Jacob M. .

HAEMATOLOGICA, 2018, 103 (10) :E489-E490

[7]

Hogan LE, 2022, J CLIN ONCOL, V40

[8] Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial [J].

Horwitz, Steven ;

O'Connor, Owen A. ;

Pro, Barbara ;

Illidge, Tim ;

Fanale, Michelle ;

Advani, Ranjana ;

Bartlett, Nancy L. ;

Christensen, Jacob Haaber ;

Morschhauser, Franck ;

Domingo-Domenech, Eva ;

Rossi, Giuseppe ;

Kim, Won Seog ;

Feldman, Tatyana ;

Lennard, Anne ;

Belada, David ;

Illes, Arpad ;

Tobinai, Kensei ;

Tsukasaki, Kunihiro ;

Yeh, Su-Peng ;

Shustov, Andrei ;

Huttmann, Andreas ;

Savage, Kerry J. ;

Yuen, Sam ;

Iyer, Swaminathan ;

Zinzani, Pier Luigi ;

Hua, Zhaowei ;

Little, Meredith ;

Rao, Shangbang ;

Woolery, Joseph ;

Manley, Thomas ;

Trumper, Lorenz ;

Aboulafia, David ;

Alpdogan, Onder ;

Ando, Kiyoshi ;

Arcaini, Luca ;

Baldini, Luca ;

Bellam, Naresh ;

Bartlett, Nancy ;

Ben Yehuda, Dina ;

Benedetti, Fabio ;

Borchman, Peter ;

Bordessoule, Dominique ;

Brice, Pauline ;

Briones, Javier ;

Caballero, Dolores ;

Carella, Angelo Michele ;

Chang, Hung ;

Cheong, June Weon ;

Cho, Seok-Goo ;

Choi, Ilseung .

LANCET, 2019, 393 (10168) :229-240

[9] T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993) [J].

Marks, David I. ;

Paietta, Elisabeth M. ;

Moorman, Anthony V. ;

Richards, Susan M. ;

Buck, Georgina ;

DeWald, Gordon ;

Ferrando, Adolfo ;

Fielding, Adele K. ;

Goldstone, Anthony H. ;

Ketterling, Rhett P. ;

Litzow, Mark R. ;

Luger, Selina M. ;

McMillan, Andrew K. ;

Mansour, Marc R. ;

Rowe, Jacob M. ;

Tallman, Martin S. ;

Lazarus, Hillard M. .

BLOOD, 2009, 114 (25) :5136-5145

[10] Relapsed T Cell ALL: Current Approaches and New Directions [J].

McMahon, Christine M. ;

Luger, Selina M. .

CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (02) :83-93

← 1 2 →